2、、AST顯著低于對(duì)照組，PA顯著高于對(duì)照組，差異有統(tǒng)計(jì)學(xué)意義（P〈0.05）。結(jié)論異甘草酸鎂及復(fù)方甘草酸苷在慢性肝炎的治療方面均有較好的效果，但是異甘草酸鎂與復(fù)方甘草酸苷比較更有優(yōu)勢(shì),值得在臨床推廣應(yīng)［關(guān)鍵詞］肝炎；異甘草酸鎂；復(fù)方甘草酸苷；病毒性肝炎酒精性脂肪性肝炎［中圖分類(lèi)號(hào)］R575.1［文獻(xiàn)標(biāo)識(shí)碼］B［文章編號(hào)］1673-9701(2016)24-0104-03[Abstract]ObjectiveTocomparetheclinicaleffectinpatientswithchronichepatitistreatedwithisogl
3、ycyrrhizinatemagnesiumandcompoundglycyrrhizin.Methods103patientswithchronichepatitiswhowereselectedfromSeptember2014toDecember2015inourhospitalwereretrospectivelyanalyzed,allthepatientsweredividedintotwogroupsaccordingtothetreatmentmethods,thestudygroup(52cases)wasgivenisoglyc
4、yrrhizinatemagnesiumtreatment,andthecontrolgroup(51cases)wasgivencompoundglycyrrhizintreatment.Theclinicalefficacyandtheliverfunctionofthetwogroupswerecomparedbeforeandaftertreatment.ResultsThetotalefficiencyofthestudygroupwassignificantlyhigherthanthatofthecontrolgroup,thedif
5、ferencewasstatisticallysignificant(P<0.05)；Aftertreatment,ALT,TBIL,ASToftwogroupsweresignificantlylowerthanthosebeforetreatment,PAwassignificantlyhigherthanthosebeforetreatment,thedifferenceswerestatisticallysignificant(P〈0.05)；ALT,TBIL,ASTofthestudygroupaftertreatmentweresign
6、ificantlowerthanthatofthecontrolgroup,PAofthestudygroupaftertreatmentwassignificanthigherthanthatofthecontrolgroup,thedifferenceswerestatisticallysignificant(P<0.05).ConclusionEffectofisoglycyrrhizinateandmagnesiumcompoundglycyrrhizininthetreatmentofchronichepatitisisbetter,bu
7、tisoglycyrrhizinatemagnesiumcompoundglycyrrhizincomparativeadvantage,itcanbeappliedinclinicalpractice.[Keywords]Hepatitis；Isoglycyrrhizinatemagnesium；Compoundglycyrrhizin;Viralhepatitis；Alcoholicsteatohepatitis慢性肝炎是我國(guó)臨床常見(jiàn)病、多發(fā)病。引發(fā)慢性肝炎的原較多，包括病毒感染、長(zhǎng)期飲酒、藥物等，患者多以腹脹、惡心、嘔吐、黃疽等為主要臨床表現(xiàn)
8、，慢性肝炎分為輕、中、重度，病情越嚴(yán)重的患者預(yù)后越差，慢性肝炎對(duì)患者的身體健康造成嚴(yán)重影響，降低患者的生活質(zhì)量［1］。近年
